Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SAMDI Tech Enters Drug Discovery Collaboration | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

SAMDI Tech Enters Drug Discovery Collaboration

Forms partnership with Enamine to expand small molecule compound libraries

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

SAMDI Tech, a provider of label-free drug discovery solutions, has partnered with Enamine, a supplier of drug-like screening compounds, to expand the number of molecules in their small molecule compound libraries. Through the partnership, SAMDI Tech will be able to offer its clients access to more than a half-million screening compounds.

“This partnership will provide us with the tools we need to continue to deliver increasingly comprehensive solutions to our clients,” said SAMDI Tech CEO Emilio Córdova. “With Enamine’s support, not only is it possible for researchers to screen for new leads against their novel targets, but our technology will allow them to narrow them down faster.”

Using its label-free and high-throughput SAMDI assay, the team at SAMDI Tech can screen a client’s target against any number of compounds. As hits are found, Enamine provides support with the follow-up chemistry needed to validate and optimize the compound’s activity.

“We are proud to expand the reach of our compound collection through SAMDI Tech,” said Irina Yavnyuk, director of business development for Enamine.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics